This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Venaxis, Inc., an in vitro diagnostic company, engages in the development and commercialization of products for unmet diagnostic and therapeutic needs. The company's research, development, and commercial activities primarily focus on a human acute appendicitis blood-based test.View APPY key stats
Venaxis Inc - APPY - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Venaxis Inc as a
Sell with a ratings score of D-.
Report Snippet: We rate VENAXIS INC (APPY) a SELL. This is driven by a few notable weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself.